Navigation Links
Howard Dean to Speak at the 2010 DTC National Conference
Date:2/10/2010

Dean scheduled to deliver keynote speech on April 7, 2010 at the J.W. Marriott Hotel in Washington D.C.

Florham Park, N.J. (PRWEB) February 10, 2010 -- DTC Perspectives, Inc., the leading conference, training and publishing company for direct-to-consumer (DTC) marketing, is proud to announce that former Vermont Governor and licensed medical doctor Howard Dean will act as a keynote speaker at the 2010 DTC National Conference to be held April 7-9 at the J.W. Marriott Hotel in Washington D.C. Dean will address the conference delegates on day one of the event (Apr. 7) by posing the question, “What is Real Healthcare Reform?” Interested parties can register for the conference at www.DTCPerspectives.com.

Former Vermont Governor Howard Dean founded Democracy for America (DFA) in 2004 to build on the grassroots momentum for reform that his bid for the presidency sparked in 2004. The movement propelled DFA into a successful national organization committed to the "50 State Strategy" with more than 1 million members. In 2005, Governor Dean was elected to chair the Democratic National Committee (DNC) and from 2005–2009 he spearheaded the DNC's support of the Democratic Party, setting up Democrats to take back Congress in 2006 and win the White House in 2008. Upon leaving the DNC early last year, Governor Dean has returned to DFA as a senior adviser on the issue of healthcare and he has become a leading commentator on the various reform proposals that moved through Congress in 2009.

Additional keynote speakers scheduled to appear at the 2010 conference include global industry leaders Steve Case, founder of AOL, and Amy Cowan, Head of Industry, Google; Pharmaceutical marketers Tom Curatolo, Product Director, Vyvanse Marketing, Shire U.S., Inc., Tim Gamble, Global Market Analytics, Pfizer Inc., Sam Trujillo, Director of Consumer Marketing, Bayer HealthCare Pharmaceuticals, Paul Stevenson, Senior Product Manager, Novo Nordisk, and Richard Baron, Executive Director of Customer Development Marketing, Boehringer Ingelheim.

The DTC National Conference is designed to provide DTC marketers with an opportunity to learn from industry thought leaders and discuss the latest innovations in DTC marketing. Over the three day conference, the more than 550 attendees benefit from case studies, new market research, media & marketing gurus and networking opportunities. Attendance is recommended for all industry members, including pharmaceutical brand team members, agency executives, media buyers and planners, market researchers, media partners and solution providers.

For more information on the 2010 DTC National Conference Agenda or for conference registration, please visit our Website, www.DTCperspectives.com or call Debra Sander at (973) 377-2106 ex 221.

DTC Perspectives, Inc. is a conference, training and publishing company that specializes in the analysis of pharmaceutical product consumer marketing. It is our goal to serve as the premier information exchange forum for DTC marketers with the publication of DTC Perspectives magazine as well as through attendance at our highly respected DTC Conference Series.


###

Read the full story at http://www.prweb.com/releases/2010/02/prweb3581444.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Excerpts from DNC Chairman Howard Deans Remarks at the National Baptist Convention
2. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against LCA-Vision Inc.
3. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Micrus Endovascular Corporation
4. UT Southwestern researcher named Howard Hughes Medical Institute investigator
5. CVS Caremarks Howard McLure Elected New PCMA Board Chairman
6. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against WellCare Health Plans, Inc.
7. Law Offices of Howard G. Smith Announces 14 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Care Investment Trust Inc.
8. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Micrus Endovascular Corporation
9. Law Offices of Howard G. Smith Announces 25 Days Remaining to Move to Be a Lead Plaintiff in the Shareholder Lawsuit Against Threshold Pharmaceuticals, Inc.
10. Law Offices of Howard G. Smith Announces Class Action Lawsuit Against Security Capital Assurance Ltd.
11. Nektar Therapeutics President and CEO, Howard W. Robin, to Present at Merrill Lynch 19th Global Pharmaceutical, Biotechnology & Medical Device Conference in New York City
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Howard Dean to Speak at the 2010 DTC National Conference 
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... 27, 2016 , ... "FCPX editors can now reveal their media with growing ... said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color brings ... users can now reveal the media of their split screens with growing colorful panels. ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... ... June 27, 2016 , ... ... announced its strategic partnership with Connance, a healthcare industry leader providing predictive ... proven, proprietary technology combine to provide health systems, hospitals and ambulatory surgical ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... ... cutting edge technology to revolutionize the emergency ambulance transport experience for the millions ... aware of how Uber has disrupted the taxi industry through the use of ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... SYDNEY , June 26, 2016 One of ... , has announced the formation of a new biotechnology company, Noxopharm ... raise $6m in an IPO and to list on the ASX. ... drug candidate, NOX66, ready to enter a Phase 1 clinical study ... been designed to address one of the biggest problems facing cancer ...
(Date:6/26/2016)... June 27, 2016 Jazz Pharmaceuticals plc (Nasdaq: ... under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as ... Celator Pharmaceuticals, Inc. ("Celator"; Nasdaq: CPXX ) ... Daylight Time). As previously announced on May ... definitive merger agreement under which Jazz Pharmaceuticals has commenced ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology: